ClinicalTrials.Veeva

Menu

Multimodal MRI-guided rTMS to Treat Refractory Hallucinations (MULTIMODHAL)

U

University Hospital, Lille

Status

Completed

Conditions

Perceptual Disorders
Schizophrenia
Hallucinations

Treatments

Device: MagPro X100 repetitive Transcranial Magnetic Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT01373866
2009-A00842-55 (Other Identifier)
2009_17/0927

Details and patient eligibility

About

  • The efficacy of neuro-navigated rTMS for patients with schizophrenia suffering from drug-resistant multisensory hallucinations will be tested by the implementation of a double-blind randomized controlled trial (RCT)
  • This study will use a combination of different MRI modalities (fMRI and DTI) to define with precision rTMS brain-targets in the case of multisensory hallucinations
  • The investigators anticipate that multimodal MRI-guided rTMS will allow a significant improvement in the efficacy of neuromodulation treatment of refractory hallucinations

Enrollment

85 patients

Sex

All

Ages

13 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Right-handed Female/Male, [13-60 y.o.],
  • Schizophrenia (DSM-IV-TR diagnosis),
  • Drug-resistant hallucinations (Kinon & Kane criteria, 1993),
  • Unmodified antipsychotic dosage during the 30 days preceding rMTS,
  • No anticonvulsive medication,
  • No neurological disorder, no addictive behavior,
  • Matched for sex, age and PANSS scores,
  • Consent to participate to the study,

Exclusion criteria

  • Pregnancy
  • Contraindication to MRI scan
  • Contraindication to rTMS treatment
  • Claustrophobia
  • No social insurance

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

85 participants in 2 patient groups

Multimodal MRI-guided rTMS
Experimental group
Treatment:
Device: MagPro X100 repetitive Transcranial Magnetic Stimulation
Device: MagPro X100 repetitive Transcranial Magnetic Stimulation
Conventional T3-P3 rTMS
Active Comparator group
Treatment:
Device: MagPro X100 repetitive Transcranial Magnetic Stimulation
Device: MagPro X100 repetitive Transcranial Magnetic Stimulation

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems